KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Current Deferred Revenue (2020 - 2025)

Hims & Hers Health (HIMS) has disclosed Current Deferred Revenue for 6 consecutive years, with $127.2 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue rose 68.92% to $127.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $127.2 million through Dec 2025, up 68.92% year-over-year, with the annual reading at $127.2 million for FY2025, 68.92% up from the prior year.
  • Current Deferred Revenue hit $127.2 million in Q4 2025 for Hims & Hers Health, up from $118.5 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $127.2 million in Q4 2025 to a low of $624000.0 in Q1 2021.
  • Historically, Current Deferred Revenue has averaged $31.4 million across 5 years, with a median of $3.8 million in 2021.
  • Biggest five-year swings in Current Deferred Revenue: tumbled 53.83% in 2022 and later skyrocketed 919.92% in 2024.
  • Year by year, Current Deferred Revenue stood at $3.2 million in 2021, then tumbled by 53.83% to $1.5 million in 2022, then surged by 425.34% to $7.7 million in 2023, then skyrocketed by 873.75% to $75.3 million in 2024, then surged by 68.92% to $127.2 million in 2025.
  • Business Quant data shows Current Deferred Revenue for HIMS at $127.2 million in Q4 2025, $118.5 million in Q3 2025, and $98.4 million in Q2 2025.